| Title |
Association between smoking and cognitive impairment in multiple sclerosis
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, September 2014
|
| DOI | 10.2147/ndt.s68389 |
| Pubmed ID | |
| Authors |
Muhammed Emin Özcan, Bahri İnce, Ayhan Bingöl, Simge Ertürk, Meriç Adil Altınöz, Hasan Hüseyin Karadeli, Abdulkadir Koçer, Talip Asil |
| Abstract |
Although smoking is known to cause various symptoms in multiple sclerosis (MS) patients, there have been no reports regarding the relationship between smoking and cognitive impairment in MS. Studying the effects of cigarette smoking in MS patients is imperative as there is a high prevalence of cognitive impairment in MS patients. In this study we examined the potentially deleterious effects of heavy smoking on mentation of patients with MS. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 67% |
| United States | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| Unknown | 57 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 9 | 16% |
| Student > Ph. D. Student | 8 | 14% |
| Researcher | 6 | 10% |
| Student > Doctoral Student | 5 | 9% |
| Professor > Associate Professor | 5 | 9% |
| Other | 16 | 28% |
| Unknown | 9 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 36% |
| Neuroscience | 8 | 14% |
| Psychology | 7 | 12% |
| Agricultural and Biological Sciences | 2 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Other | 6 | 10% |
| Unknown | 12 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2020.
All research outputs
#15,091,901
of 25,374,647 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,408
of 3,132 outputs
Outputs of similar age
#122,922
of 248,671 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#26
of 52 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,671 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.